Last $2,184 MXN
Change Today 0.00 / 0.00%
Volume 0.0
MCK* On Other Exchanges
New York
As of 4:08 PM 04/14/14 All times are local (Market data is delayed by at least 15 minutes).

mckesson corp (MCK*) Snapshot

Previous Close
Day High
Day Low
52 Week High
03/20/14 - $2,457
52 Week Low
04/19/13 - $1,283
Market Cap
Average Volume 10 Days
Shares Outstanding
Dividend Yield
Current Stock Chart for MCKESSON CORP (MCK*)

mckesson corp (MCK*) Details

McKesson Corporation, together with its subsidiaries, delivers pharmaceuticals, medical supplies, and health care information technologies to the healthcare industry primarily in the United States. It operates in two segments, McKesson Distribution Solutions and McKesson Technology Solutions. The McKesson Distribution Solutions segment distributes ethical and proprietary drugs, medical-surgical supplies and equipment, and health and beauty care products in North America. This segment also provides specialty pharmaceutical solutions for biotech and pharmaceutical manufacturers; and practice management, technology, clinical support, and business solutions to oncology and other specialty practices operating in the community setting. In addition, this segment sells financial, operational, and clinical solutions for retail, hospital, and alternate site pharmacies; and provides consulting and outsourcing services. The McKesson Technology Solutions segment delivers enterprise-wide clinical, patient care, financial, supply chain, and strategic management software solutions, as well as pharmacy automation solutions for hospitals; and connectivity, claims processing, outsourcing, and other services, including remote hosting and managed services to healthcare organizations. This segment also offers InterQual clinical criteria solution, claims payment solutions, and network performance tools. This segment’s customers include hospitals, physicians, homecare providers, retail pharmacies, and payers in North America, the United Kingdom, Ireland, other European countries, and Israel. McKesson Corporation was founded in 1833 and is headquartered in San Francisco, California.

43,500 Employees
Last Reported Date: 05/7/13
Founded in 1833

mckesson corp (MCK*) Top Compensated Officers

Chairman, Chief Executive Officer and Preside...
Total Annual Compensation: $1.7M
Executive Vice President and Group President
Total Annual Compensation: $1.1M
Executive Vice President and President of McK...
Total Annual Compensation: $684.0K
President of McKesson Specialty Health
Total Annual Compensation: $679.5K
Chief Compliance Officer, Executive Vice Pres...
Total Annual Compensation: $686.0K
Compensation as of Fiscal Year 2013.

mckesson corp (MCK*) Key Developments

Ohio Attorney General Mike Dewine Announces Settlement in Drug Pricing Lawsuit against Mckesson Corporation

Ohio Attorney General Mike DeWine announced that his office has reached an $18.325 million settlement in a lawsuit brought against McKesson Corporation for an alleged scheme to inflate the price of drugs prescribed for beneficiaries of the Ohio Public Employees Retirement System, State Teachers Retirement System of Ohio and the Ohio Bureau of Workers' Compensation. The Attorney General's lawsuit, filed in May 2013, accused the company of a conspiracy to inflate average wholesale prices of hundreds of brand-name drugs that are used by OPERS, STRS Ohio, and the BWC to set prescription drug reimbursement rates.

McKesson Announces QICS(TM) for Cardiology

McKesson announced a new cardiology solution that helps hospitals do more with less. QICS(TM) (Qualitative Intelligence and Communication System) for Cardiology helps organizations automate and manage cardiology workflows to promote better efficiency and effectiveness. The solution to offer integrated workflows and critical results communications management within the cardiovascular information system (CVIS). OSF Healthcare in Peoria, Ill., is piloting QICS for Cardiology to save time for clinicians, meet regulatory requirements and improve overall quality. Additionally, QICS for Cardiology provides a reliable communication system to help improve patient care by facilitating the care continuum. In the past, a department manager would have to pick up the phone and issue an internal page to communicate critical results and activate the care team. Now, critical results messages are available within the CDS to help expedite emergency care.

McKesson Corporation Appoints N. Anthony Coles as New Independent Director

On February 28, 2014, the Board of Directors of McKesson Corporation, upon recommendation of the Committee on Directors and Corporate Governance, elected N. Anthony Coles, M.D., as a new director, effective April 29, 2014. Dr. Coles term as a director will expire at the company’s 2014 Annual Meeting of Stockholders unless he is renominated as a director, and elected by stockholders at the annual meeting in accordance with the company’s majority voting standard. The size of the Board was increased from nine to ten members in connection with Dr. Coles’ election. Dr. Coles was President, Chief Executive Officer and Chairman of the Board of Onyx Pharmaceuticals Inc. from 2012 until 2013, having served as its President and Chief Executive Officer, and a member of its board of directors, from 2008 until 2012. The Board has appointed Dr. Coles as a member of the Compensation Committee and the Finance Committee.


Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
MCK*:MM $2,183.54 MXN 0.00

MCK* Competitors

Market data is delayed at least 15 minutes.

Company Last Change
AmerisourceBergen Corp $64.95 USD +0.73
Cardinal Health Inc $68.02 USD +0.81
Express Scripts Holding Co $73.18 USD -0.444
UnitedHealth Group Inc $78.19 USD -1.32
Walgreen Co $66.16 USD +0.15
View Industry Companies

Industry Analysis


Industry Average

Valuation MCK* Industry Range
Price/Earnings 31.6x
Price/Sales 0.3x
Price/Book 4.8x
Price/Cash Flow 33.7x
TEV/Sales 0.2x

Post a JobJobs

View all jobs

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact MCKESSON CORP, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at